No Data
No Data
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
Vaxart to Present at the Citizens Life Sciences Conference
Express News | Vaxart Inc - Topline Data From Phase 1 Trial Expected Mid-2025
Express News | Vaxart Completes Enrollment in Phase 1 Trial for Its Norovirus Oral Pill Vaccine Candidate
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23